Luebke, A. M., Attarchi-Tehrani, A., Meiners, J., Hube-Magg, C., Lang, D. S., Kluth, M., . . . Höflmayer, D. (2019). Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers. Cancer Biol Med.
Chicago ZitierstilLuebke, Andreas M., et al. "Loss of PSP94 Expression Is Associated With Early PSA Recurrence and Deteriorates Outcome of PTEN Deleted Prostate Cancers." Cancer Biol Med 2019.
MLA ZitierstilLuebke, Andreas M., et al. "Loss of PSP94 Expression Is Associated With Early PSA Recurrence and Deteriorates Outcome of PTEN Deleted Prostate Cancers." Cancer Biol Med 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.